Michel Sadelain Awarded the 2025 King Faisal Prize in Medicine
April 21, 2024
Dr. Michel Sadelain received the 2024 Breakthrough Prize in Life Sciences for the development of chimeric antigen receptor T cell immunotherapy, whereby the patient’s T cells are modified to target and kill cancer cells. For the development of chimeric antigen receptor T cell immunotherapy, whereby the patient’s T cells are modified to target and kill cancer cells.
(The relevant segment begins at 53:30)